Search

Home > New FDA Approvals > 079 - FDA statement on radiofrequency energy exposure and cancer; upcoming FDA decisions
Podcast: New FDA Approvals
Episode:

079 - FDA statement on radiofrequency energy exposure and cancer; upcoming FDA decisions
Category: Science & Medicine
Duration: 00:08:20
Publish Date: 2018-02-05 07:00:00
Description:

February 5, 2018

3:43 FDA statement on radiofrequency energy exposure and cancer

https://www.nih.gov/news-events/news-releases/high-exposure-radiofrequency-radiation-linked-tumor-activity-male-rats

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm595144.htm

Upcoming FDA decisions:

AMAG Pharmaceuticals Inc. Makena (sNDA) FDA decision on Makena subcutaneous auto-injector for subcutaneous use to reduce the risk of preterm birth in women who are pregnant with one baby and who spontaneously delivered one preterm baby in the past 02/14/2018

Valeant Pharmaceuticals International PLENVU (NDA) FDA decision on PLENVU for cleansing of the colon in preparation of colonoscopy 02/13/2018

Gilead Sciences Inc. Bictegravir (NDA) FDA decision on Bictegravir for the treatment of HIV-1 infection 02/12/2018
Total Play: 0